[Beat therapeutic inertia in dyslipidemic patient management: A challenge in daily clinical practice] [corrected]

Clin Investig Arterioscler. 2014 Jul-Aug;26(4):193-9. doi: 10.1016/j.arteri.2014.01.004. Epub 2014 Mar 16.
[Article in Spanish]

Abstract

Beat therapeutic inertia in dyslipidemic patient management: a challenge in daily clinical practice. In patients with dyslipidemia, there is the need to reach the therapeutic goals in order to get the maximum benefit in the cardiovascular events risk reduction, especially myocardial infarction. Even having guidelines and some powerful hypolipidemic drugs, the goals of low-density lipoprotein-cholesterol (LDL-c) are often not reached, being of special in patients with a high cardiovascular risk. One of the causes is the therapeutic inertia. There are tools to plan the treatment and make the decisions easier. One of the challenges in everyday clinical practice is to know the needed percentage of reduction in LDL-c. Moreover: it is hard to know which one is the treatment we should use in the beginning of the treatment but also when the desired objective is not reached. This article proposes a practical method that can help solving these questions.

Keywords: Dislipidemia; Dyslipidemia; Inercia terapéutica; LDL-c; Planificación terapéutica; Therapeutic inertia; Therapy planning; cLDL.

Publication types

  • English Abstract

MeSH terms

  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Cholesterol, LDL / blood*
  • Dyslipidemias / complications
  • Dyslipidemias / therapy*
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Practice Guidelines as Topic
  • Risk Factors

Substances

  • Cholesterol, LDL
  • Hypolipidemic Agents